Eikon Therapeutics
Founded Year
2019Stage
Series C | AliveTotal Raised
$771.8MLast Raised
$106M | 1 yr agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-86 points in the past 30 days
About Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company focused on the discovery and development of novel treatments for life-threatening diseases. The company offers a platform that integrates engineering, science, and advanced microscopy to visualize and measure protein movement in living cells, aiding in the identification of new drug targets and the development of therapeutics. Eikon's pipeline includes programs in oncology, immunology, and neuroscience. It was founded in 2019 and is based in Hayward, California.
Loading...
Loading...
Expert Collections containing Eikon Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eikon Therapeutics is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,244 items
Eikon Therapeutics Patents
Eikon Therapeutics has filed 1 patent.
The 3 most popular patent topics include:
- biotechnology
- cell imaging
- fluorescent dyes
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/26/2022 | Molecular biology, Microscopy, Cell imaging, Fluorescent dyes, Biotechnology | Application |
Application Date | 7/26/2022 |
|---|---|
Grant Date | |
Title | |
Related Topics | Molecular biology, Microscopy, Cell imaging, Fluorescent dyes, Biotechnology |
Status | Application |
Latest Eikon Therapeutics News
Aug 26, 2024
HAYWARD, Calif.--(BUSINESS WIRE)-- #Biotech--Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that CEO and Board Chair, Roger M. Perlmutter, M.D., Ph.D., and CFO, Alfred “Freddie” Bowie, Ph.D., will provide a business update at Morgan Stanley’s 22nd Annual Global Healthcare Conference in New York City on September 4, 2024 at 8:30am ET. Their presentation will cover recent advancements in the company’
Eikon Therapeutics Frequently Asked Questions (FAQ)
When was Eikon Therapeutics founded?
Eikon Therapeutics was founded in 2019.
Where is Eikon Therapeutics's headquarters?
Eikon Therapeutics's headquarters is located at 3929 Point Eden Way, Hayward.
What is Eikon Therapeutics's latest funding round?
Eikon Therapeutics's latest funding round is Series C.
How much did Eikon Therapeutics raise?
Eikon Therapeutics raised a total of $771.8M.
Who are the investors of Eikon Therapeutics?
Investors of Eikon Therapeutics include The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital, Hartford HealthCare Endowment and 16 more.
Loading...
Loading...